Elicio Therapeutics Inc（ELTX）价格预测ELTXElicio Therapeutics Inc

Alphio's ELTX stock price prediction model matches the current Elicio Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.49 (-0.17%). The 1-week path is $1.51 (+1.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Elicio Therapeutics Inc (ELTX) is currently not a strong buy due to its recent performance and financial instability. The current price is $1.49, significantly down from its 52-week high of $16.00, indicating a decline of 90.69%. The RSI is at 39.55, suggesting that the stock is nearing oversold territory, but the overall trend remains bearish. The company has reported substantial net losses, with a net income of -$14 million in Q4 2024, and the forward P/E ratio is negative, reflecting ongoing financial challenges. The main risk is the company's reliance on funding through offerings, as highlighted by the recent $15 million offering to support clinical development, which may dilute existing shares and further impact stock performance.

Elicio Therapeutics Inc (ELTX) last closed at $1.49, gaining +6.43%. These facts feed the 1-day and 1-week ELTX price prediction above.